Klonopin Statistics

Outright Klonopin misuse is rare; the quieter risk is dependence in people taking it exactly as prescribed. Here's how the numbers break down by age, why mixing turns fatal, and why a supervised taper makes recovery the rule.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

Klonopin Statistics in Plain Numbers

If you are trying to size up how common Klonopin problems really are, or how worried to be about a prescription that has quietly become a daily habit, the numbers here give you a clear picture. Klonopin (clonazepam) is one of the most-prescribed benzodiazepines in the country, its real danger shows up when it is mixed with opioids or alcohol, and dependence builds quietly even in people who never misuse it.

Klonopin is the brand name for clonazepam, a high-potency, long-acting benzodiazepine[1]. The data here come from national surveys, emergency-department records, and overdose registries. Every figure is sourced to a study, and where a clean Klonopin-specific number does not exist, that gap is noted rather than filled with a guess.

Getting off Klonopin the safe way is gentler than the fear makes it look. Call 988 if you're in danger.
If you’re in danger right now or thinking about suicide, call or text 988 (Suicide & Crisis Lifeline), any time.

What to do:

  • Get into a medically supervised taper — this is the safe way off Klonopin, and its long half-life makes the drop between dose reductions one of the steadier ones to ride out[2]. See how Klonopin detox works →
  • Tell every prescriber you’re on Klonopin — the real danger lives in mixing it with opioids or alcohol, so the people writing your scripts need the full picture[3].
  • Call 911 if someone won’t wake up — naloxone reverses opioids but not Klonopin, so give it if opioids may be involved, then call 911 anyway.

Find treatment today →

AddictionHelp.com Fast Facts
  • Clonazepam is the third most-prescribed benzodiazepine in US emergency departments — it accounted for 15.2% of all benzodiazepine ED-discharge prescriptions from 2012 to 2019, behind only diazepam and alprazolam[4].
  • Benzodiazepine misuse is real but far from universal — only about 2% of the US population misused a benzodiazepine in the past year, so dependence is most often something that develops in people taking it as prescribed, not recreational abuse[5].
  • The danger is in the mix — benzodiazepines were involved in roughly 1 in 6 prescription-depressant overdose deaths in one statewide cohort, almost always alongside opioids, fentanyl, or cocaine[6].

How Often Klonopin Is Prescribed

Clonazepam is one of the most widely prescribed benzodiazepines in the United States, and the clearest fingerprint of that is in emergency-department data. Between 2012 and 2019, there were 13,848,578 visits where a benzodiazepine was prescribed at ED discharge[4].

Inside that total, clonazepam is a heavy hitter:

  • Diazepam (Valium) led with 5,980,279 visits (43.2%) of all benzodiazepine ED prescriptions[4]
  • Alprazolam (Xanax) was next at 3,306,549 visits (23.9%)[4]
  • Clonazepam (Klonopin) ranked third at 2,105,963 visits (15.2%)[4]

So when you reach for a benzodiazepine in this country, there is a strong chance it is one of those three, and clonazepam is squarely among the leaders. A drug this commonly dispensed is one a lot of people end up taking far longer than planned, which is the backdrop for every other number that follows[1].

Benzodiazepine Prescribing Has Held Steady, Not Fallen

Despite years of warnings, the prescribing has not dropped. Across the 2012-to-2019 ED data, benzodiazepines were prescribed at roughly 1.1% of all ED visits in 2012 and 0.9% in 2019, with no significant trend over the period[4].

The lesson in those numbers is that benzodiazepine use is entrenched, not fading, which is part of why so many people quietly slide into dependence.

How Common Klonopin Misuse Really Is

What 'misuse' means hereMisuse means taking a medication in a way the prescriber did not intend, or taking it without a prescription at all. It is a separate thing from the physical dependence that can build even when you follow the label exactly.

Here is the number that should take some fear down a notch. Most people who run into trouble with Klonopin are not recreational abusers. Past-year benzodiazepine misuse — taking it in a way a prescriber did not intend, or without a prescription — runs at only about 2% of the US population, based on the 2015-to-2019 National Survey on Drug Use and Health[5].

For the broader category of prescription tranquilizers (benzodiazepines plus muscle relaxants), the 2021-to-2023 national survey estimated that about 1.1 million US adults reported past-month misuse, which works out to roughly 0.5% of adults[7].

The share of people misusing these drugs is small, and the bigger story is physical dependence forming in people who follow the label exactly[1]. That is a medical process, not a moral failing.

One Real Gap in the Klonopin Numbers

A caution before the demographic data. National surveys rarely break out clonazepam by name — they fold it into “benzodiazepines” or “prescription tranquilizers/sedatives,” so most prevalence figures describe the class, not Klonopin specifically[5][8]. Where a figure is class-wide, that is flagged. Clonazepam’s standing as a top-three prescribed benzodiazepine means the class numbers track it closely[4].

Who Misuses Klonopin, by Age and Sex

The demographics of benzodiazepine and tranquilizer misuse are consistent across studies, and they split mainly by age.

Young Adults Have the Highest Misuse Rates

The 18-to-25 group stands out. In the 2015-to-2016 national survey, young adults aged 18-25 had the highest prevalence of past-year and past-month tranquilizer/sedative misuse of any age band, and 42.8% of young adults who used these medications at all also misused them[8].

Opioid misuse traveled closely alongside it. Across age groups, opioid misuse was the substance-use factor most strongly tied to tranquilizer/sedative misuse — exactly the combination that drives overdose risk[8].

Older Adults Have a Different, Quieter Risk

Older adults misuse these drugs less often, but their pattern is its own problem. Past-year misuse abstinence actually rises with age — from 80.5% at ages 50-54 to 96.0% among those 80 and older — so outright misuse thins out in the oldest groups[9].

The catch is the source. Among older adults who do misuse, the doctor’s office is the main supply: adults 65 and older had the highest physician-source use, at 38.2%[10]. And older people who got their medication from a physician fared worse than those who got it free from friends or family, with far higher rates of past-year opioid misuse (58.6% versus 34.9%) and serious psychological distress (50.1% versus 11.6%)[10].

Group Klonopin-class misuse pattern Key figure Source
Young adults (18-25) Highest misuse rates of any age band 42.8% of users misused [8]
Adults 50-54 Lower misuse, but present 80.5% abstinent (19.5% any PDM) [9]
Adults 80+ Misuse rare 96.0% abstinent [9]
Adults 65+ Doctor is the main source 38.2% physician-sourced [10]
Older physician-source users Worse outcomes than free/family source 50.1% vs 11.6% serious distress [10]

The face of Klonopin misuse is not one type of person. It is a young adult mixing it with opioids on one end, and an older adult quietly escalating a legitimate prescription on the other. Both are real, and both are treatable.

Sex Differences Show Up in Overdose Deaths

When benzodiazepine harm turns fatal, sex patterns emerge. In a North Carolina overdose analysis, overdoses involving opioids, benzodiazepines, and antiepileptics were predominantly among women (60.6%), even though men made up two-thirds of opioid-only overdose deaths[11]. A separate emergency-department analysis identified a distinct overdose group best described as female, older than 55, and benzodiazepine-involved, which made up 8.0% of suspected-overdose ED visits[12].

Where Klonopin Dependence Comes From

Klonopin’s pull is built into its pharmacology, and the numbers behind that are worth knowing. Clonazepam is high-potency and long-acting, with an elimination half-life of roughly 20 to 80 hours[2]. Taken regularly, the brain remodels its own GABA-A receptors so the same dose does less over time — that is tolerance — and stopping then brings withdrawal[13].

The clearest data on how dependence escalates come from following people over decades.

In a national cohort tracked from age 18 toward age 50, by age 35:

  • 70.9% had never used or misused prescription benzodiazepines[14]
  • 11.3% reported medical use only[14]
  • 9.8% reported both medical use and misuse[14]
  • 14.1% reported misuse only[14]

Even “as Prescribed” Raises Later Risk

The most sobering finding in that cohort is what happened to people who only ever took benzodiazepines as prescribed. Compared with adults who never used them, medical-only users by age 35 had about 2.17 times the odds of later benzodiazepine misuse, and elevated odds of later opioid misuse as well[14].

That is not a reason to fear a needed prescription. It is the data behind a simple rule: the longer Klonopin stays in the picture, the more carefully it needs watching, because legitimate use is itself a risk signal for later trouble[14].

Did you know?

In a national study that followed people from their teens toward age 50, taking prescription benzodiazepines strictly as a doctor ordered — never misusing them — was still linked to roughly 2.17 times the odds of later benzodiazepine misuse compared with people who never used them at all[14]. Dependence does not require breaking the rules.

Why Klonopin Overdose Is Almost Always About Mixing

What 'polysubstance' meansPolysubstance means more than one drug is in the body at the same time. With Klonopin, the worry is stacking it with another central-nervous-system depressant like an opioid or alcohol, because each one slows breathing on its own.

Taken alone, benzodiazepines like Klonopin are relatively forgiving compared with opioids. The fatal danger shows up in combination, and the overdose data make that unmistakable.

In a Massachusetts cohort of 8,665 overdose deaths involving prescription depressants from 2000 to 2023, the benzodiazepine-related deaths clustered into mixed-drug classes[6]:

  • Fentanyl, cocaine, and benzodiazepines made up 34.4% of these deaths[6]
  • Prescription opioids and benzodiazepines made up 19.5%[6]

In other words, when a benzodiazepine like Klonopin shows up in an overdose death, another central-nervous-system depressant is almost always there too[6].

The Opioid-Plus-Benzo Combination Drives the Risk

The opioid-benzodiazepine pairing is the dangerous one across every dataset. In a North Carolina analysis, opioids and benzodiazepines were the second most common fatal drug combination, present in 9.0% of overdose deaths, behind only opioids-and-stimulants[11]. Polysubstance overdose death in that state rose sharply over the decade, from 2.9 to 12.1 deaths per 100,000 people[11].

The risk also compounds when prescriptions come from different doctors. Among more than half a million patients taking opioids and benzodiazepines together, overdose happened on 7.0 per 100,000 person-days when the prescriptions came from multiple prescribers, versus 3.9 per 100,000 from a single prescriber — about 1.8 times the risk[3]. Even a small number of people carry serious danger here: roughly 1 in 231 of those co-prescribed patients had a treated overdose[3].

Klonopin-class overdose statistic The number Source
Deaths involving fentanyl, cocaine, and benzodiazepines 34.4% of Rx-depressant deaths [6]
Deaths involving Rx opioids and benzodiazepines 19.5% of Rx-depressant deaths [6]
Opioid + benzodiazepine fatal combination 9.0% of overdose deaths [11]
Polysubstance OD death rise, one decade 2.9 to 12.1 per 100,000 [11]
Overdose risk, multiple vs single prescriber 7.0 vs 3.9 per 100,000 person-days [3]
Co-prescribed patients with an overdose About 1 in 231 (0.4%) [3]

Naloxone Reverses Opioids, Not Klonopin

One life-or-death distinction the numbers point to: because most benzodiazepine deaths are mixed with opioids, naloxone (Narcan) still matters — it reverses the opioid part[6]. But it does not reverse Klonopin, so call 911 regardless, since the benzodiazepine effect and the breathing risk can continue after the opioid is reversed.

How Klonopin Shows Up in Overdose Deaths

Beyond the combinations, two patterns in fatal-overdose data are worth pulling out, because they reshape who is at risk.

A Large Share of Deaths Involve Nonmedical Use

In a Tennessee study linking overdose deaths to prescription records, researchers could tell whether a person actually had a prescription for the drug in their system. Among 7,281 overdose deaths, 16.7% (1,216) involved nonmedical benzodiazepine use — the drug was present on toxicology, but the person had no active prescription for it[15]. Overall, 33% of those deaths involved some form of nonmedical prescription-drug use[15].

The takeaway is blunt: a meaningful share of benzodiazepine deaths involve pills obtained outside a pharmacy, which is also where counterfeit and contaminated tablets enter the picture[1].

Older Prescribing Patterns Drive a Risk Most People Miss

The prescription characteristics themselves carry signal. In a Medicare cohort of adults prescribed benzodiazepines, 0.78% of new users and 0.56% of continuing users had a treated overdose within 30 days of a prescription[16]. The biggest amplifier was a concurrent opioid prescription, which raised overdose risk by roughly 1.7 times[16]. High-risk prescribing is not rare, either: in one statewide analysis, high-risk opioid prescriptions — including those paired with a benzodiazepine — made up 12.6% of all opioid prescriptions[17].

What the Klonopin Numbers Add Up To

A number is not a verdictStatistics describe a whole population, not your future. They point to where the risk lives so you can sidestep it, and the way out of dependence is well understood once you decide to take it.

Read together, the statistics tell a consistent story:

  • Klonopin is everywhere in prescribing — a top-three benzodiazepine by ED-discharge volume[4]
  • Outright misuse is uncommon — about 2% of the population, so most trouble is dependence in people taking it as directed[5][1]
  • Even prescribed use raises later risk — by roughly 2.17 times for benzodiazepine misuse down the road[14]
  • The deaths are almost always mixed — with opioids and alcohol the deadly partners[6][11]

None of that makes Klonopin a uniquely evil drug. It means a medication this common and this quietly habit-forming deserves more respect than it usually gets — and the safe way off is a supervised taper, never stopping suddenly on your own[13]. For the wider class picture, dig into the benzodiazepine statistics and how benzodiazepines work and why they hook people.

Klonopin Addiction Statistics

Pulling the headline addiction-related figures into one place:

  • Clonazepam ED-discharge share — 15.2% of all benzodiazepine ED prescriptions, third nationally[4]
  • Past-year benzodiazepine misuse — about 2% of the US population[5]
  • Prescription-tranquilizer misuse — roughly 1.1 million US adults in a recent year[7]
  • Highest-misuse age band — young adults 18-25, with 42.8% of users misusing[8]
  • Later-misuse odds after medical-only use — about 2.17 times[14]
  • Benzodiazepine-involved overdose deaths — 16.7% involved nonmedical use in one statewide cohort[15]
  • Overall benzodiazepine harm — the benzodiazepine/z-drug class carried the greatest burden in treatment demand, overdoses, and deaths in a national study, present in 546 of every 1,000 drug-related deaths[18]

The single thread running through all of it is hopeful: dependence is the predictable biology of a drug the brain adapted to, and that biology runs in reverse once a supervised taper begins[13][19].

Getting Help for Klonopin Addiction

If these numbers describe you or someone you love, the encouraging part is that the way out is well understood and it works. A slow, structured taper under medical supervision brings most people off clonazepam safely, and Klonopin’s own long half-life works in your favor by smoothing the drop between dose reductions[19][2].

The path forward usually runs through a few clear steps:

  • A supervised taper plus support is the proven core, since no single medication “cures” benzodiazepine dependence and the taper-plus-therapy combination gives the best odds[19].
  • The danger is in stopping the wrong way, not in stopping — abrupt withdrawal is what risks seizures, which is exactly why a supervised taper is the safe route[13].
  • Tell every prescriber you are on Klonopin, since the overdose data are clear that combining it with opioids or alcohol is where the real risk lives[6][3].

You do not have to feel ready, and you do not have to be tough. A named problem is a treatable one, the way out is gentler than the fear makes it look, and recovery is the expected outcome, not the exception[19]. For the bigger picture of who Klonopin affects and how to recognize a problem, start with Klonopin (clonazepam) and how dependence forms.

If any of this lands, the next step doesn’t have to be a big one. Our treatment centers directory can point you to the right level of care. Reaching out today is a real step forward — and one you can make right now.

Frequently asked questions

How common is Klonopin compared to other benzodiazepines?

Clonazepam (Klonopin) is one of the most-prescribed benzodiazepines in the United States. In a national analysis of emergency-department discharge prescriptions from 2012 to 2019, clonazepam was the third most common benzodiazepine prescribed, making up 15.2% of all benzodiazepine ED prescriptions, behind diazepam (Valium) at 43.2% and alprazolam (Xanax) at 23.9%[4]. Across that whole period there were nearly 13.9 million ED visits where a benzodiazepine was sent home, and the rate did not meaningfully fall over time[4]. So Klonopin is squarely among the leaders of a drug class that remains heavily used.

How many people misuse Klonopin?

Outright misuse is less common than most people assume. Based on the National Survey on Drug Use and Health from 2015 to 2019, only about 2% of the US population misused a benzodiazepine in the past year[5]. For the broader category of prescription tranquilizers, roughly 1.1 million US adults reported past-month misuse in 2021 to 2023, about 0.5% of adults[7]. National surveys rarely break out clonazepam by name, so these are class-wide figures[5]. The practical point is that most Klonopin trouble is physical dependence in people taking it exactly as prescribed, not recreational abuse[1].

Who is most likely to misuse Klonopin?

Misuse splits mainly by age. Young adults aged 18 to 25 have the highest rates of benzodiazepine and tranquilizer misuse of any age group, and in one national survey 42.8% of young adults who used these medications also misused them[8]. Older adults misuse them less often, but when they do, the doctor’s office is the main source: adults 65 and older had the highest physician-source use at 38.2%[10]. Across ages, opioid misuse is the factor most strongly tied to benzodiazepine misuse, which is exactly the combination that drives overdose risk[8].

Can you get addicted to Klonopin even if you take it as prescribed?

Yes, and the data show it plainly. Taken regularly, clonazepam leads the brain to remodel its own GABA-A receptors, producing tolerance and physical dependence even at prescribed doses[13]. In a national cohort followed from the teens toward age 50, adults who used benzodiazepines only as a doctor prescribed, never misusing them, still had about 2.17 times the odds of later benzodiazepine misuse compared with people who never used them at all[14]. That is not a reason to fear a needed prescription, but it is why long-term use needs careful monitoring.

How dangerous is a Klonopin overdose?

Klonopin taken alone is relatively forgiving compared with opioids, but the fatal danger shows up in combination. In a Massachusetts cohort of 8,665 prescription-depressant overdose deaths, benzodiazepines clustered into mixed-drug groups: 34.4% involved fentanyl, cocaine, and benzodiazepines, and 19.5% involved prescription opioids and benzodiazepines[6]. In North Carolina, the opioid-plus-benzodiazepine combination was present in 9.0% of overdose deaths[11]. Risk climbs further when prescriptions come from multiple doctors rather than one[3]. Naloxone reverses the opioid part of a mixed overdose but does not reverse Klonopin, so always call 911.

Can you recover from Klonopin dependence?

Yes. Klonopin dependence is treatable, and recovery is the expected outcome rather than the exception. The proven approach is a slow, structured taper under medical supervision paired with counseling, since no single medication cures benzodiazepine dependence and the taper-plus-therapy combination gives the best odds[19]. The one thing to avoid is stopping suddenly on your own, because abrupt withdrawal is what risks seizures[13]. Klonopin’s long half-life actually works in your favor during a taper by smoothing the drop between dose reductions[2]. You can find treatment and people who can help at /find-treatment-help/.

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

19 Sources
  1. Dokkedal-Silva V, Berro LF, Galduróz JCF, Tufik S, Andersen ML (2019). Clonazepam: Indications, Side Effects, and Potential for Nonmedical Use. Harvard review of psychiatry. https://doi.org/10.1097/hrp.0000000000000227
  2. Greenblatt DJ, Miller LG, Shader RI (1987). Clonazepam pharmacokinetics, brain uptake, and receptor interactions. The Journal of clinical psychiatry.
  3. Chua K, Brummett CM, Ng S, Bohnert ASB (2021). Association Between Receipt of Overlapping Opioid and Benzodiazepine Prescriptions From Multiple Prescribers and Overdose Risk. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2021.20353
  4. Ramdin C, Mina G, Nelson L, Mazer-Amirshahi M (2024). Benzodiazepine Discharge Prescriptions From Emergency Departments Across the United States Between 2012 and 2019: A National Analysis. Journal of addiction medicine. https://doi.org/10.1097/adm.0000000000001310
  5. McHugh RK, Votaw VR, Trapani EW, McCarthy MD (2023). Prevalence and correlates of the misuse of z-drugs and benzodiazepines in the National Survey on Drug Use and Health. Frontiers in psychiatry. https://doi.org/10.3389/fpsyt.2023.1129447
  6. Lee H, Dong H, Jalali MS, Stringfellow EJ (2026). Prescription Depressant-Involved Overdose Mortality in Massachusetts (2000-2023): A Cohort Study. Journal of general internal medicine. https://doi.org/10.1007/s11606-025-10113-8
  7. Lee J, Ahlquist J, Parker M (2025). Higher Prescription Tranquilizer Misuse Among Bisexual Individuals in the United States, 2021-2023. Substance use & misuse. https://doi.org/10.1080/10826084.2025.2491771
  8. Schepis TS, Teter CJ, Simoni-Wastila L, McCabe SE (2018). Prescription tranquilizer/sedative misuse prevalence and correlates across age cohorts in the US. Addictive behaviors. https://doi.org/10.1016/j.addbeh.2018.06.013
  9. Schepis TS, Ford JA, Wastila L, McCabe SE (2021). Opioid-involved prescription drug misuse and poly-prescription drug misuse in U.S. older adults. Aging & mental health. https://doi.org/10.1080/13607863.2020.1839859
  10. Schepis TS, McCabe SE (2019). Prescription Tranquilizer/Sedative Sources for Misuse in Older Adults. Substance use & misuse. https://doi.org/10.1080/10826084.2019.1613434
  11. Figgatt MC, Austin AE, Cox ME, Proescholdbell S, Marshall SW, Naumann RB (2021). Trends in unintentional polysubstance overdose deaths and individual and community correlates of polysubstance overdose, North Carolina, 2009-2018. Drug and alcohol dependence. https://doi.org/10.1016/j.drugalcdep.2020.108504
  12. Liu S, Vivolo-Kantor A (2020). A latent class analysis of drug and substance use patterns among patients treated in emergency departments for suspected drug overdose. Addictive behaviors. https://doi.org/10.1016/j.addbeh.2019.106142
  13. Miller LG (1991). Chronic benzodiazepine administration: from the patient to the gene. Journal of clinical pharmacology. https://doi.org/10.1002/j.1552-4604.1991.tb03725.x
  14. McCabe SE, Schulenberg JE, Wilens TE, Schepis TS, McCabe VV, Veliz P (2023). Transitions in Prescription Benzodiazepine Use and Misuse and in Substance Use Disorder Symptoms Through Age 50. Psychiatric services (Washington, D.C.). https://doi.org/10.1176/appi.ps.20220247
  15. Korona-Bailey J, Moses J, Mukhopadhyay S (2025). Assessing Prevalence of Nonmedically Used Prescription Drug Involvement in Overdose Deaths Through Linkage of State Unintentional Drug Overdose Reporting System and Controlled Substances Monitoring Program Data. Substance use & misuse. https://doi.org/10.1080/10826084.2025.2454653
  16. Maust DT, Bohnert ASB, Strominger J, Goldstick JE (2023). Prescription characteristics associated with drug overdose risk among adults prescribed benzodiazepines: a cohort study. BMC pharmacology & toxicology. https://doi.org/10.1186/s40360-023-00674-x
  17. Sangalli L, Bolch C, Rojas-Ramirez MV (2026). Trend in Opioid Analgesic Prescriptions and High-Risk Prescribing in the State of Illinois: An Eight-Year Descriptive Analysis. Journal of public health dentistry. https://doi.org/10.1111/jphd.70039
  18. Durand L, Arensman E, Corcoran P, Daly C, Bennett K, Lyons S, et al. (2025). Harms associated with prescription drug misuse in Ireland: A national observational study of trends in treatment demand, non-fatal intentional drug overdoses and drug related deaths 2010-2020. Drug and alcohol dependence. https://doi.org/10.1016/j.drugalcdep.2025.112669
  19. da Silva LGR, da Silva Pinto AW, de Queiroz WE, Coelho CC, Blatt CR, Oliveira MG, et al. (2022). Deprescribing clonazepam in primary care older patients: a feasibility study. International journal of clinical pharmacy. https://doi.org/10.1007/s11096-021-01371-7
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.